Other Organic Chemical terms — page 68 | HESTIA Glossary
Browse all 9,913 other organic chemical terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.
- 4-((3-((Dimethylphenyl)azo)-2,4-dihydroxyphenyl)azo)benzene sulphonic acid, Monosodium salt D & C Brown no. 1; EINECS 215-296-9
- 4-((4'-Tolythio)methyl)-3-nitrobenzoic acid 4-[[(4-Methylphenyl)thio]methyl]-3-nitrobenzoic acid; Benzoic acid, 4-(((4-methylphenyl)thio)methyl)-3-nitro-; 4-((4'-Tolythio)methyl)-3-nitrobenzoic acid
- 4-((4-((((4-Methoxy-2-nitrophenyl)amino)carbonyl)amino)benzoyl)amino)butanoic acid 4-[[4-[[[(4-Methoxy-2-nitrophenyl)amino]carbonyl]amino]benzoyl]amino]butanoic acid; Golden Yellow; Golden Yellow
- 4-((4-(Diethylamino)phenyl)azo)pyridine 1-oxide N,N-DIETHYL-4-(4'-[PYRIDYL-1'-OXIDE]AZO)ANILINE; Pyridine, 4-((4-(diethylamino)phenyl)azo)-, 1-oxide; 4-((4-(Diethylamino)phenyl)azo)pyridine 1-oxide
- 4-(1,1,3,3-Tetramethylbutyl)phenol, Sodium derivative
- 4-(1,1,3,3-Tetramethylbutyl)resorcinol 4-tert-Octylresorcinol; 28122-52-3; 4-(2,4,4-trimethylpentan-2-yl)benzene-1,3-diol; 4-(1,1,3,3-tetramethylbutyl)benzene-1,3-diol; p-tert-Octylresorcinol; YQOJNENEFSZINP-UHFFFAOYSA-N; NSC3949; 4-t-octyl resorcinol; ACMC-209h0z; SCHEMBL70826; CTK4G0879; DTXSID70277762; ALBB-023335; NSC-3949; ZINC1672920; ZX-AN021849; ANW-26337; AKOS003368797; MCULE-9913348276; ACM28122523; KS-000015F6; 4-(1,1,3,3-Tetramethylbutyl)resorcinol; AS-66980; DB-047342; TC-115082; FT-0638761; O0048; R1767; ST45024094; 1,3-Benzenediol,4-(1,1,3,3-tetramethylbutyl)-; 4-(1,1,3,3-Tetramethylbutyl)-1,3-benzenediol; AT-057/43342873; 1,3-Benzenediol, 4-(1,1,3,3-tetramethylbutyl)-; 4-(1,1,3,3-Tetramethylbutyl)-1,3-benzenediol #
- 4-(1,1-Dimethylethyl)-1,1-dimethoxycyclohexane
- 4-(1,1-Dimethylethyl)-2,6-dinitrobenzenamine Benzenamine, 4-(1,1-dimethylethyl)-2,6-dinitro-; 22503-16-8; Aniline, 4-tert-butyl-2,6-dinitro-; 4-tert-Butyl-2,6-dinitroaniline; Butralin metabolite; 4-t-butyl-2,6-dinitroaniline; SCHEMBL11870893; CTK8H6817; DTXSID30346706; CUTHFSYWMSPYOS-UHFFFAOYSA-N; DNTBA 4-tert-butyl-2,6-dinitroaniline; 4-(1,1-Dimethylethyl)-2,6-dinitrobenzenamine
- 4-(1,1-Dimethylethyl)-2-ethoxybenzoic acid
- 4-(1,1-Dimethylethyl)-2-nitro-6-nitrosobenzenamine
- 4-(1,1-Dimethylethyl)-N-(1-methylpropyl)-2-nitrobenzenamine
- 4-(1,1-Dimethylpropyl)-2-methylphenol
- 4-(1,2-Dichloroethyl)-1,2-dichlorocyclohexane 1,2-Dichloro-4-(1,2-dichloroethyl)cyclohexane; 1,2-dichloro-4-(1,2-dichloroethyl)cyclohexane; 51962-63-1; NSC75249; 4-(1,2-DICHLOROETHYL)-1,2-DICHLOROCYCLOHEXANE; DTXSID50966288; NSC14508; NSC-14508; NSC-75249; 4-(1,2-Dichloroethyl)-1,2-dichlorocyclohexane
- 4-(1,3,3,3-Tetrachloropropyl)-1-cyclohexene
- 4-(1-Adamantyl)phenol 4-Tricyclo[3.3.1.13,7]dec-1-ylphenol; 4-(1-Adamantyl)phenol; NSC 111653
- 4-(1-Ethyl-1,3-dimethylpentyl)-2-nitrophenol
- 4-(1-Ethyl-1,3-dimethylpentyl)phenol 4-(1-Ethyl-1,3-dimethylpentyl)phenol; 186825-36-5; Phenol, 4-(1-ethyl-1,3-dimethylpentyl)-; 353 Nonylphenol; 4-[1-ethyl-1,3-dimethylpentyl]phenol; 4-(3,5-DIMETHYL-3-HEPTYL)PHENOL; P-353NP; (+/-)-4-(1-Ethyl-1,3-dimethylpentyl)phenol; RYIHVIPUIXFRNI-UHFFFAOYSA-N; 4-(3,5-Dimethylheptane-3-yl)phenol; Phenol, 4-(1-ethyl-1,3-dimethylpentyl); 4-(3,5-DIMETHYLHEPTAN-3-YL)PHENOL; J-012011; 4-(3,5-Dimethyl-3-heptyl)phenol, analytical standard; Q27261080; UNII-5394ZPD91W
- 4-(1-Ethyl-1,4-dimethylpentyl)phenol 142731-63-3; 4-(1-Ethyl-1,4-dimethylpentyl)phenol; Phenol, 4-(1-ethyl-1,4-dimethylpentyl)-; 4-(3',6'-Dimethyl-3'-heptyl)phenol; 4-(3,6-dimethylheptan-3-yl)phenol; 4-[1-ethyl-1,4-dimethylpentyl]phenol; 4-(3 inverted exclamation mark ,6 inverted exclamation mark -Dimethyl-3 inverted exclamation mark -heptyl)phenol; 4-Nonylphenol 112; P-363NP; ACMC-20eiie; (+/-)-4-(1-Ethyl-1,4-dimethylpentyl)phenol; 4-(1-Ethyl-1,4-dimethylpentyl)phenol, (+/-)-; CTK0F0143; BGLUSMSXKMBLFS-UHFFFAOYSA-N; 4-(3,6-Dimethylheptane-3-yl)phenol; AKOS028114104; 4-(1-Ethyl-1,4-dimethyl-pentyl)phenol; 4-(1-ethyl-1,4-dimethylpentyl)-phenol; Phenol, 4-(1-ethyl-1,4-dimethylpentyl); RT-009136; FT-0667453; J-007687; 4-(3,6-Dimethyl-3-heptyl)phenol, analytical standard; Q27260841; UNII-510794F9KY
- 4-(2,3-Dichlorophenoxy)butanoic acid
- 4-(2,4-Dinitroanilino)phenol 4-[(2,4-Dinitrophenyl)amino]phenol; 4-(2,4-Dinitroanilino)phenol; Disperse Yellow 1; 119-15-3; Reliton Yellow R; Amacel Yellow RR; Disperse Yellow R; Perliton Yellow RR; Supracet Yellow RR; Fast Disperse Yellow 2K; Acetamine Yellow 2R; Permanent Yellow 2K; Setacyl Yellow P-BS; Cilla Fast Yellow RR; Microsetile Yellow 2R; Nyloquinone Yellow 2R; Serisol Fast Yellow A; Kayalon Fast Yellow RR; Celliton Fast Yellow RR; Dispersol Fast Yellow A; Fenacet Fast Yellow 2R; Disperse Fast Yellow 2K; p-(2,4-Dinitroanilino)phenol; Supracet Fast Yellow 2R; SRA Golden Yellow VIII; C.I. Disperse Yellow 1; Synten yellow P 2R; Dispersol Printing Yellow A; Dispersol Yellow B-A; Celliton Fast Yellow RRA-CF; Acetoquinone Light Yellow 2RZ; 4-[(2,4-Dinitrophenyl)amino]phenol; Disperse Yellow Stable 2K; C.I. Solvent Yellow 52; N-2,4-Dinitrophenyl-4-aminophenol; 2,4-Dinitro-4'-hydroxydiphenylamine; 4-Hydroxy-2',4'-dinitrodiphenylamine; Phenol, 4-[(2,4-dinitrophenyl)amino]-; 2,4-Dinitro-p-hydroxydiphenylamine; Phenol, p-(2,4-dinitroanilino)-; C.I. 10345; NSC 13965; CCRIS 4630; Zolcien syntenowa P-2R [Polish]; EINECS 204-300-4; 4-((2,4-Dinitrophenyl)amino)phenol; BRN 2223171; Phenol, 4-((2,4-dinitrophenyl)amino)-; AI3-01810; BCPQALWAROJVLE-UHFFFAOYSA-N; 4'-Hydroxy-2,4-dinitrodiphenylamine; C.I. Leuco Sulphur Blue 11; N-(4-Hydroxyphenyl)-2,4-dinitroaniline; Phenol,4-dinitroanilino)-; W-109435; W-111185; Phenol,4-dinitrophenyl)amino]-; Zolcien syntenowa P-2R; 61902-31-6; EINECS 310-132-3; C.I. Sulphur Blue 5; CBDivE_002130; SCHEMBL2328147; DTXSID4025161; p-(2,4-Dinitroanilino)-phenol; CTK4B1094; NSC6335; 4-(2,4-dinitro-anilino)-phenol; 4-(2,4-dinitrophenylamino)phenol; NSC-6335; NSC13965; STR05486; ZINC3861608; 6084AF; LS-613; NSC-13965; NSC408078; SBB001098; AKOS000286102; MCULE-5854603780; NSC-408078; Phenol,4-[(2,4-dinitrophenyl)amino]-; CC-16225; ST036780; C.I.10345; DB-041448; FT-0625341; C-30955; N-(2,4-Dinitrophenyl)-N-(4-hydroxyphenyl)amine; SR-01000195250; SR-01000195250-1; Leuco polysulfided 4-((2,4-dinitrophenyl)amino)phenol; 4-(2,4-DINITROANILINO)PHENOL (SEE ALSO: 2-(2,4-DINITROANILINO)PHENOL (CAS 6358-23-2)); InChI=1/C12H9N3O5/c16-10-4-1-8(2-5-10)13-11-6-3-9(14(17)18)7-12(11)15(19)20/h1-7,13,16; C.I. Disperse Yellow 1; C.I. 10345
- 4-(2,5-Dichlorophenoxy)butanoic acid
- 4-(2-(2-Pyridylethylamino) ethyl)-morpholine
- 4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulphonamide 5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide; 16673-34-0; 5-Chloro-2-methoxy-N-(4-sulfamoylphenethyl)benzamide; NLRP3 Inflammasome Inhibitor I; 5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide; UNII-8TF6P2NUB5; 8TF6P2NUB5; 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]phenylsulphonamide; N-(2-(4-sulfamoyl)phenyl)ethyl-5-chloro-2-methoxybenzamide; N-(2-(4-(Aminosulphonyl)phenyl)ethyl)-5-chloro-2-methoxybenzamide; 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]phenylsulfonamide; 4-[2-(2-Methoxy-5-chlorobenzamido)ethyl]benzene sulfonamide; 4-(2-(5-CHLORO-2-METHOXYBENZAMIDO)ETHYL)PHENYLSULFONAMIDE; Glibenclamide impurity A (4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonamide); SR-01000945190; EINECS 240-722-5; ACMC-209uxb; 5-Chloro-2-methoxy-N-[2-(4-sulfamoyl-; phenyl)-ethyl]-benzamide; EC 240-722-5; DSSTox_CID_31449; DSSTox_RID_97335; DSSTox_GSID_57660; Oprea1_786605; Oprea1_846330; DK-1; IFLab1_000209; SCHEMBL8993421; CHEMBL3188223; DTXSID1057660; CTK4D2430; AOB2464; SYN5142; Glyburide USP Related Compound A; KVWWTCSJLGHLRM-UHFFFAOYSA-N; 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzene Sulfonamide; HMS1412J11; ZINC641902; BCP13822; Tox21_113826; ANW-44349; s3680; STK039139; AKOS000592467; MCULE-7070512861; VZ28081; IDI1_008428; NCGC00253706-01; NCGC00253706-02; AC-18743; AS-16506; CAS-16673-34-0; DB-043663; TC-133094; FT-0637396; ST24029443; ST50232470; SR-01000945190-1; SR-01000945190-2; W-107916; 5-chloro-2-methoxy-N-(4-sulfamoylphenethyl_benzamide; 5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]b; 4-[2-(5-Chloro-2-methoxybenzamido)ethyl] phenylsulphonamide; 5-chloro-2-methoxy-N-[2-(4-sulfamoyl-phenyl) ethyl]-benzamide; N~1~-[4-(aminosulfonyl)phenethyl]-5-chloro-2-methoxybenzamide; p-(2-{5-chloro-2-methoxybenzamido}ethyl)-benzene sulfonamide; 5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide, 95%; Benzamide,N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxy-; (5-chloro-2-methoxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]carboxamide; Glibenclamide impurity A, European Pharmacopoeia (EP) Reference Standard; Glyburide Related Compound A, United States Pharmacopeia (USP) Reference Standard; 4-[2-(5-Chloro-2-methoxybenzamido) ethyl] benzenesulfonamide; N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxy-benzamide; 5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide; 4-[2-(2-Methoxy-5-chlorobenzene-1-carboxamido)ethyl]benzenesulfonamide; N-(2-(4-(Aminosulphonyl)phenyl)ethyl)-5-chloro-2-methoxybenzamide; EINECS 240-722-5
- 4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; norepinephrine; noradrenaline; L-Noradrenaline; Arterenol; Levarterenol; 51-41-2; Levophed; (-)-Norepinephrine; L-Norepinephrine; (R)-Noradrenaline; (R)-Norepinephrine; L-arterenol; (-)-Arterenol; Levonor; (-)-NORADRENALINE; Levonorepinephrine; Adrenor; Aktamin; Levonoradrenaline; Sympathin E; (R)-(-)-Norepinephrine; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; Noradrenalin; Norepirenamine; norepinephrinum; Levoarterenol; Noradrenalinum; Norartrinal; Nor-Epirenan; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; L-3,4-dihydroxyphenylethanolamine; Levarterenolo [DCIT]; D-(-)-Noradrenaline; Noradrenalina [Italian]; Noradrenalin, l-; l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; (-)-(R)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; Noreinefrina [INN-Spanish]; Nor adrenalin (TN); Norepinephrinum [INN-Latin]; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-; UNII-X4W3ENH1CV; Noradrenalina; NOREPINEPHIRINE; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-; EINECS 200-096-6; X4W3ENH1CV; BRN 4231961; CHEMBL1437; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-; CHEBI:18357; SFLSHLFXELFNJZ-QMMMGPOBSA-N; 138-65-8; (R)-4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol; Levarterenolo; Noreinefrina; 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; 1,2-Benzenediol,4-(2-amino-1-hydroxyethyl)-; W-105896; d-Arterenol; 1,2-Benzenediol, 4-((R)-2-amino-1-hydroxyethyl)-; d-Norepinephrine; xi-Norepinephrine; norepinefrina; Ecteinascidins; Nor adrenalin; (+)-Noradrenaline; Norepinephrine [INN:JAN]; Norepinephrine (INN); Noradrenaline (JP15); Norepinephrine l-Tartrate (1:1); (-)-Arterenol free base; Norepinephrine Noradrenalin; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-; Nor-adrenaline; R-norepinephrine; DermX; MFCD00025592; Norepinephrine [INN:BAN:JAN]; HSDB 7772; Adrenaline Impurity; ALBB-006229; (?)-Norepinephrine; PubChem6074; Spectrum_001009; Noradrenaline (JP17); Spectrum2_001064; Spectrum3_000520; Spectrum4_000078; Spectrum5_001068; DSSTox_CID_3378; bmse000404; SCHEMBL2609; DSSTox_RID_77004; DSSTox_GSID_23378; BSPBio_002079; GTPL505; KBioGR_000635; KBioSS_001489; MLS006010883; DivK1c_000230; SPECTRUM1500436; SPBio_001048; Levarterenol; Levophed; Arterenol; 4-[(1R)-2-amino-1-hydroxy-ethyl]benzene-1,2-diol; SGCUT00123; DTXSID5023378; CTK4C1344; HMS500L12; KBio1_000230; KBio2_001489; KBio2_004057; KBio2_006625; KBio3_001579; ZINC57624; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; NINDS_000230; HMS1920B08; HMS2089E18; HMS2091J08; Pharmakon1600-01500436; to_000024; Tox21_301944; ANW-74377; BDBM50029051; CCG-40104; FCH920095; NSC757246; PDSP1_001111; PDSP2_001095; s9507; STK503776; AKOS006345192; AKOS015854572; API0003193; DB00368; NSC-757246; SDCCGSBI-0050082.P004; CAS-51-41-2; IDI1_000230; NCGC00159406-03; NCGC00159406-04; NCGC00159406-05; NCGC00159406-06; NCGC00159406-07; NCGC00159406-08; NCGC00159406-09; NCGC00159406-10; NCGC00159406-11; NCGC00255328-01; AS-56654; CC-33071; HY-13715; LS-42676; SC-04955; SMR000058585; (-)-Norepinephrine, >=98%, crystalline; (R)-4-(2-Amino-1-hydroxyethyl)catechol; SBI-0050082.P003; TR-005105; CS-0007744; FT-0603221; FT-0658803; FT-0679201; 4786-EP2270011A1; 4786-EP2280010A2; 4786-EP2284171A1; 4786-EP2287163A1; 4786-EP2287165A2; 4786-EP2287166A2; 4786-EP2292620A2; 4786-EP2298776A1; 4786-EP2305644A1; 4786-EP2305648A1; 4786-EP2305677A1; 4786-EP2305678A1; 4786-EP2308864A1; 4786-EP2308873A1; 4786-EP2308875A1; 4786-EP2311831A1; 4786-EP2314571A2; 4786-EP2316836A1; C-4015; C00547; D00076; 21779-EP2269990A1; 21779-EP2272847A1; 21779-EP2284170A1; 21779-EP2287165A2; 21779-EP2287166A2; 21779-EP2292620A2; 21779-EP2298731A1; 21779-EP2298742A1; 21779-EP2305669A1; 21779-EP2311828A1; 21779-EP2311835A1; 21779-EP2314571A2; 21779-EP2377510A1; AB00052424-06; AB00052424_07; AB00052424_08; 025N592; C-05156; Q186242; UNII-K294OAI79V component SFLSHLFXELFNJZ-QMMMGPOBSA-N; (-)-NORADRENALINE/ 1,?2-?Benzenediol, 4-?[(1R)?-?2; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI); 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(-)-; Benzyl alcohol, .alpha.-(aminomethyl)-3,4-dihydroxy-, (+)-; (-)-NORADRENALINE/ 1,?2-?Benzenediol, 4-?[(1R)?-?2-?amino-?1-?hydroxyethyl]?-; Norepinephrine, DL-; dl-Arterenol
- 4-(2-Aminoethyl)benzenesulphonyl fluoride hydrochloride 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (1:1); Benzenesulfonyl fluoride, p-(2-aminoethyl)-, hydrochloride; Pefabloc SC
- 4-(2-Bromoethoxy)benzophenone 4-(2-Bromoethoxy)benzophenone; 38459-64-2; SCHEMBL6338785; CTK1A8896; DTXSID20542513; RGTVYJNIILDRKZ-UHFFFAOYSA-N; ZINC19516702; AKOS000197796; [4-(2-Bromoethoxy)phenyl](phenyl)methanone; J3.494.088F; Methanone, [4-(2-bromoethoxy)phenyl]phenyl-
- 4-(2-Butenyl)phenol p-Crotylphenol; 4-(2-BUTENYL)PHENOL; Phenol, p-2-butenyl-; p-2-Butenylphenol; Phenol, 4-(2-butenyl)-; 13037-71-3; NSC 19678; BRN 2241201; UNII-E73YFW4Z77; AI3-22175; E73YFW4Z77; NSC19678; WLN: QR D2U2; SCHEMBL111719; ZINC1866906; NSC-19678; Phenol, 4-(2-butenyl)- (9CI); LS-104116; AI3-22175
- 4-(2-Chloro-5-methylphenoxy)butanoic acid
- 4-(2-Chloroethoxy)benzophenone 4-(2-Chloroethoxy)benzophenone; 3439-73-4; Methanone, [4-(2-chloroethoxy)phenyl]phenyl-; [4-(2-Chloroethoxy)phenyl]-phenylmethanone; SCHEMBL10795926; 4-(2-chloroethoxy) benzophenone; CTK1B7731; DTXSID40474589; AKOS009293578; A1-05773; EC 690-635-5
- 4-(2-Furyl)-3-buten-2-one Furfurylideneacetone; 623-15-4; 4-(2-Furyl)-3-buten-2-one; Furfurylideneacetone; Furfural acetone; 4-(furan-2-yl)but-3-en-2-one; FAM polymer; Oramin R; 3-Buten-2-one, 4-(2-furanyl)-; Oramin Special GR; Furfuralacetone polymer; Polyfurfurylidineacetone; FURFURALACETONE; Furfurylideneacetone resin; 3-Buten-2-one, 4-(2-furyl)-; Furfurylidene acetone polymer; UNII-0W86Y87AUR; Poly(monofurfurylideneacetone); 2-Furfurylideneacetone polymer; furfurylidene acetone; Monofurfurylideneacetone; Furfuryl acetone; Monomer FAM; FAM (monomer); 4-(2-Furyl)but-3-en-2-one; 3-Buten-2-one, 4-(2-furanyl)-, homopolymer; 3-Butene-2-one, 4-(2-furanyl)-; (3E)-4-(2-furyl)but-3-en-2-one; (E)-4-(furan-2-yl)but-3-en-2-one; 0W86Y87AUR; 3-Buten-2-one, 4-(2-furanyl)-, polymers; NSC643044; 2-Furfurylideneacetone; 4-(2-Furyl)-3-buten-2-one, predominantly cis; FEMA No. 2495; CCRIS 6241; 4-(2-Furanyl)-3-buten-2-one; NSC 2065; NSC 6104; EINECS 210-774-3; AI3-05777; trans-Furfurylideneacetone; Furfuralaceton; 108811-61-6; 3-Buten-2-one, 4-(2-furyl)-, polymers; 3-Buten-2-one, 4-(2-furyl)- (6CI,8CI); 3-Buten-2-one, 4-(2-furyl)-, polymers (8CI); 25398-39-4; SCHEMBL370268; CHEMBL105424; furfural acetone, No Antioxidant; GBKGJMYPQZODMI-SNAWJCMRSA-; NSC2065; NSC6104; GBKGJMYPQZODMI-SNAWJCMRSA-N; ZINC154592; NSC-2065; NSC-6104; 8060AF; GEO-01454; MFCD00039566; SBB056697; (E)-4-furan-2-ylbut-3-en-2-one; (E)-4-(2-furyl)but-3-en-2-one; AKOS000121297; (E)-4-(2-Furyl)-3-buten-2-one; NE10946; NSC-643044; (Z)-4-(2-Furanyl)-3-butene-2-one; 1-ACETYL-2-(2-FURYL)ETHYLENE; NCGC00248709-01; LS-47307; (3E)-4-(furan-2-yl)but-3-en-2-one; (E)-4-(furan-2-yl)-but-3-en-2-one; (3E)-4-(2-Furyl)-3-buten-2-one #; RT-019982; TC-122899; F0235; ST45028955; 4-(2-Furyl)-3-buten-2-one (mixture of isomers); J-002193; Q27231187; 4-(2-FURYL)-3-BUTEN-2-ONE, 95%, PREDOMIN ANTLY CIS; InChI=1/C8H8O2/c1-7(9)4-5-8-3-2-6-10-8/h2-6H,1H3/b5-4+; Monofurfurylideneacetone; AI3-05777
- 4-(2-Hydroxyethoxy)benzophenone, Acetate
- 4-(2-Hydroxyethyl)-1-piperazine ethanesulphonic acid 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid; HEPES; 5-23-02-00379 (Beilstein Handbook Reference)
- 4-(2-Hydroxyphenyl)but-3-en-2-one 4-(2-Hydroxyphenyl)-3-buten-2-one; 2-hydroxybenzalacetone; 4-(2-Hydroxyphenyl)but-3-en-2-one; 22214-28-4; (E)-4-(2-hydroxyphenyl)but-3-en-2-one; (3E)-4-(2-hydroxyphenyl)but-3-en-2-one; (E)-4-(2-Hydroxy-phenyl)-but-3-en-2-one; 6051-53-2; 4-(2-hydroxyphenyl)-3-buten-2-one; AO-840/40184794; salicylideneacetone; MLS000680174; EINECS 227-957-9; AI3-23864; o-Hydroxystyrylmethyl ketone; 3-Buten-2-one, 4-(o-hydroxyphenyl)-, (E)-; CHEMBL412355; SCHEMBL1404928; DTXSID50875902; OIKUPYQBJLSNAS-VOTSOKGWSA-N; HMS2614A14; NSC61817; ZINC2028945; FCH830731; NSC-61817; SBB087612; STL192036; 4-(O-hydroxyphenyl)-3-buten-2-one; AKOS001326226; FCH3500290; 3-Buten-2-one,4-(2-hydroxyphenyl)-; 3-Buten-2-one, 4-(2-hydroxyphenyl)-; 4-(2-Hydroxy-phenyl)-but-3-en-2-one; NCGC00246603-01; SMR000324439; (E)-4-(2-hydroxyphenyl)-3-buten-2-one; (E)-4-(2-Hydroxyphenyl)-3-butene-2-one; ST45102633; L-4522; 4-(o-Hydroxyphenyl)-3-buten-2-one, sodium salt; A833685; F0400-0013; 3-Buten-2-one, 4-(2-hydroxyphenyl)-; AI3-23864
- 4-(2-Naphthylamino)phenol 93-45-8; 4-(naphthalen-2-ylamino)phenol; p-Oxinozon; 4-(2-NAPHTHYLAMINO)PHENOL; p-(2-Naphthylamino)phenol; p-Hydroxyneozon; Phenol, 4-(2-naphthalenylamino)-; p-Oxyneozone; p-Hydroxyneozone; p-Hydroxyphenyl-2-naphthylamine; 2-(4'-Hydroxyphenylamino)-Naphthalene; 4-(2-Naphthalenylamino)phenol; Phenol, p-(2-naphthylamino)-; 4-(2-Naftylamino)fenol; N-(4-Hydroxyphenyl)-2-naphthylamine; NSC 15372; p-(beta-Naphthylamino)phenol; CCRIS 6073; p-Hydroxyphenyl-beta-naphthylamine; 4-(2-Naftylamino)fenol [Czech]; N-p-Hydroxyphenyl-2-naphthylamine; 4-Hydroxyphenyl-beta-naphthylamine; N-p-Hydroxyphenyl-beta-naphthylamine; EINECS 202-248-7; BRN 1642793; UNII-391R4KT1XJ; MLS002638427; 391R4KT1XJ; p-(.beta.-Naphthylamino)phenol; Phenol,4-(2-naphthalenylamino)-; RACMGQBQYYWANW-UHFFFAOYSA-N; 4-Hydroxyphenyl-.beta.-naphthylamine; N-(p-Hydroxyphenyl)-2-naphthylamine; p-Hydroxyphenyl-.beta.-naphthylamine; N-(p-Hydroxyphenyl)-.beta.-naphthylamine; WLN: L66J CMR DQ; W-109346; NSC21065; p-(2-naphthylamino) phenol; 3-13-00-01031 (Beilstein Handbook Reference); BIDD:GT0834; SCHEMBL593005; CHEMBL1699265; DTXSID8025701; Phenol, 4-(2-naphthylamino)-; CTK5H2546; ZINC18550; HMS3089F24; 4-[(naphthalen-2-yl)amino]phenol; KS-000011MN; NSC15372; NSC-15372; NSC-21065; AKOS021984255; LS-1943; LS40523; VZ23156; AK151213; AS-61152; CC-05856; SMR001547908; AX8016286; DB-057402; 4CH-025092; FT-0631466; ST24043117; C-13894; N-(4-HYDROXYPHENYL)-2-NAPHTHYLAMINE, 97; Q27890213; 3-13-00-01031 (Beilstein Handbook Reference)
- 4-(2-Nitro-1-propenyl)quinoline
- 4-(2-Nitrovinyl)quinoline
- 4-(3-Hydroxy-1,5-dimethylhexyl)-1-cyclohexene-1-carboxylic acid, Methyl ester
- 4-(3-Oxobutyl)phenyl formate 4-[4-(Formyloxy)phenyl]-2-butanone; 4-(3-Oxobutyl)phenyl formate; 84604-55-7; EINECS 283-336-2; CTK5F2775; DTXSID30233586; ZINC33608021; 4-[4-(Formyloxy)phenyl]-2-butanone; 2-Butanone,4-[4-(formyloxy)phenyl]-; formic acid 4-(3-oxobutyl) phenyl ester; 4-(3-Oxobutyl)phenyl formate; EINECS 283-336-2
- 4-(3-Phosphonopropyl)piperazine-2-carboxylic acid 4-(3-Phosphonopropyl)-2-piperazinecarboxylic acid; 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid; DL-3-(2-Carboxypiperazin-4-yl)-propyl-1-phosphonic acid
- 4-(3-Tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one 4-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazol-2-one; Cgp-12177; Tbhpbo; Cgp 12177; Cgp 12177A; 81047-99-6; 4-(3-tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one; CHEBI:73288; [3H]CGP 12177; CGP12177A; CGP-12177A; C14H19N3O3; 4-[3-(tert-butylamino)-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazol-2-one; 2H-Benzimidazol-2-one, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,3-dihydro-; (+/-)-CGP-12177A hydrochloride; [3H]CGP12177; [3H]-CGP12177; Spectrum_001907; SpecPlus_000776; Spectrum4_000777; CGP-12177A hydrochloride; Lopac0_000372; GTPL532; KBioGR_001194; KBioSS_002444; DivK1c_006872; CHEMBL420746; GTPL5387; SCHEMBL2016211; BDBM25747; CTK5E8414; KBio1_001816; KBio2_002438; KBio2_005006; KBio2_007574; DTXSID901001733; CGP12177; BDBM50027879; 2H-Benzimidazol-2-one, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-; 4-[3-(tert-butylamino)-2-hydroxypropoxy]-1,3-dihydrobenzimidazol-2-one; CCG-204467; SDCCGSBI-0050360.P003; NCGC00015184-03; NCGC00015184-04; NCGC00015184-05; NCGC00025024-02; NCGC00025024-03; LS-177605; FT-0708718; L000166; BRD-A34706053-003-01-9; Q27075889; 7-[3-(tert-Butylamino)-2-hydroxypropoxy]-1H-benzimidazol-2-ol; 2H-Benzimidazol-2-one,4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-; 4-[3-(tert-butylamino)-2-hydroxypropoxy]-2,3-dihydro-1H-1,3-benzodiazol-2-one; 4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2h-benzimidazol-2-one; 4-[3-(tert-butylamino)-2-hydroxypropoxy]-2,3-dihydro-1H-1,3-benzodiazol-2-one hydrochloride; CGP 12177; 4-(3-tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one
- 4-(4-Aminophenyl)butanoic acid 4-Aminobenzenebutanoic acid; 4-(P-aminophenyl)butyric acid
- 4-(4-Chloro-2-cyano-1H-imidazol-5-yl)benzoic acid 4-(5-Chloro-2-cyano-1H-imidazol-4-yl)benzoic acid; 4-(4-Chloro-2-cyano-1H-imidazol-5-yl)benzoic acid; UNII-RWL7V2X6YD
- 4-(4-Chlorophenoxy)aniline 4-(4-Chlorophenoxy)benzenamine; 4-(4-Chlorophenoxy)aniline; 101-79-1; 4-Amino-4'-chlorodiphenyl ether; Benzenamine, 4-(4-chlorophenoxy)-; p-(p-Chlorophenoxy)aniline; 4-(4-Chlorophenoxy)benzenamine; 4-Chloro-4'-aminodiphenyl ether; Aniline, p-chlorophenoxy-; 4-Amino-4-chlorodiphenyl ether; 4'-Chloro-4-aminobiphenyl ether; NSC 75571; ANILINE, p-(p-CHLOROPHENOXY)-; EINECS 202-976-5; BRN 0782540; 4-(4'-chlorophenoxy)aniline; 4-Amino-4'-chlorodiphenylether; 4-Chloro-4'-aminodiphenylether; CHEMBL1521156; 4-[(4-chlorophenyl)oxy]aniline; YTISFYMPVILQRL-UHFFFAOYSA-N; 4-(4-chloro-phenoxy)-phenylamine; MFCD00043925; Q63088169; 4'-chloro-4-amino diphenyl ether; NSC75571; 4-chlorophenoxyaniline; PubChem9035; DSSTox_CID_275; WLN: ZR DOR DG; Cambridge id 5128184; DSSTox_RID_75479; NCIOpen2_004533; DSSTox_GSID_20275; Oprea1_021499; CBDivE_002845; 3-13-00-00999 (Beilstein Handbook Reference); KSC500E6H; MLS000532683; 4-Amino-4-chlorodiphenylether; SCHEMBL177721; 4-(4'-chlorophenoxy) aniline; 4-(4-chlorophenoxy)phenylamine; 4-(4-chlorophenyloxy) aniline; 4-Chloro-4-aminodiphenyl ether; DTXSID1020275; 4-amino-4'-chloro diphenylether; CTK4A0263; KS-00000YPQ; ZINC14479; [4-(4-chlorophenoxy)phenyl]amine; 4-Amino-4'-chlorodiphenyl ether; Benzenamine,4-(4-chlorophenoxy)-; HMS2483B24; 4-(4-Chlorophenoxy)aniline, 97%; Tox21_200985; ANW-74828; BBL027992; BDBM50334279; NSC-75571; STK360048; AKOS000101561; AM82873; CC-1015; LS-7262; MCULE-7046718387; PS-7880; RTR-000440; VZ28257; NCGC00245707-01; NCGC00245707-02; NCGC00258538-01; AC-15759; AK-25253; CAS-101-79-1; SC-78443; SMR000140121; SY035502; TR-000440; BB 0237088; FT-0617510; ST24032695; ST50407219; A-8306; A26493; SR-01000196380; SR-01000196380-1; W-109379; BRD-K58076685-001-06-5; Z57124587; 4-(4-chlorophenoxy)-benzenamin; 4-chloro-4-aminobiphenylether; Aniline, p-(p-chlorophenoxy)-; 3-13-00-00999 (Beilstein Handbook Reference)
- 4-(4-Nitrophenylazo)-1-naphthol 4-[(4-Nitrophenyl)azo]-1-naphthalenol; 1-Naphthalenol, 4-((4-nitrophenyl)azo)-; 4-16-00-00224 (Beilstein Handbook Reference)
- 4-(4-Nitrophenylazo)phenol 4-[(4-Nitrophenyl)azo]phenol; 4-(4-NITROPHENYLAZO)PHENOL; 1435-60-5; 4-Hydroxy-4'-nitroazobenzene; 4-((4-Nitrophenyl)azo)phenol; 4-[(4-Nitrophenyl)azo]phenol; Phenol, 4-((4-nitrophenyl)azo)-; Phenol, 4-[(4-nitrophenyl)azo]-; Phenol, 4-(2-(4-nitrophenyl)diazenyl)-; Phenol, 4-[2-(4-nitrophenyl)diazenyl]-; NSC45166; NSC 45166; ACMC-1BZC4; 4-(4-nitro-phenylazo)phenol; 4-nitro-4'-hydroxyazobenzene; 4-(4'-Nitrophenylazo)phenol; 4-Nitro-4'-oxylatoazobenzene; 4-nitro-4'-hydroxy-azobenzene; SCHEMBL4278062; CHEMBL2204743; DTXSID2061690; SCHEMBL17088267; CTK4C3709; NRJPVIOTANUINF-UHFFFAOYSA-N; 4-[(4-nitrophenyl)diazenyl]phenol; ANW-20794; NSC-45166; AKOS024340808; ZINC100009138; ZINC100009140; ZINC254392989; MCULE-2596079353; (E)-4-((4-nitrophenyl)diazenyl)phenol; Phenol,4-[2-(4-nitrophenyl)diazenyl]-; TC-109539; N0653; ST50557770; 4-[(E)-2-(4-nitrophenyl)-1-diazenyl]phenol; Phenol, 4-(2-(4-nitrophenyl)diazenyl)-; 4-Hydroxy-4'-nitroazobenzene
- 4-(4-Nitrophenylazo)resorcinol 4-[-(4-Nitrophenyl)azo]-1,3-benzenediol; Magneson; AI3-09041
- 4-(4-Nitrophenylsulphonyl)aniline 4-[(4-Nitrophenyl)sulfonyl]benzenamine; 4-Nitro-4'-aminodiphenyl sulfone; NADS
- 4-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid CD-367
- 4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulphonamide 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; 170569-86-5; SC-236; SC 236; SC236; SC-58236; 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; SC 58236; CHEMBL282093; 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; NSQNZEUFHPTJME-UHFFFAOYSA-N; UNII-9HGW1H8S2M; 9HGW1H8S2M; SCHEMBL215932; CTK6G9656; GTPL10242; DTXSID80432082; HMS3262A06; ZINC600558; Tox21_500722; BDBM50057527; AKOS024457872; compound 1f [PMID: 9135032]; API0008437; CCG-222026; CS-W011699; DB14059; NCGC00261407-01; NCGC00370982-02; LS-31451; ZINC000000600558; RT-015669; SC-236, >=98% (HPLC); B7533; FT-0674529; J-010629; 4-[5(4-chlorophenyl)-3-trifluoromethyl-1H-pyrazol-1yl]benzenesulfonamide; 4-[5-(4-Chloro-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide; 4-[5-(4-chlorophenyl)-3-trifluoromethyl-1h-pyrazol-1-yl]benzenesulfonamide; 4-[5-(4-chlorophenyl)-3-trifluoromethyl-1H-pyrazol-1yl]benzenesulfonamide; 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl] benzenesulfonamide; 4-(5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide; SC-58236
- 4-(Acetyloxy)-3-nitrobenzoic acid 3-Nitro-4-acetoxybenzoic acid; Benzoic acid, 4-(acetyloxy)-3-nitro-; 4-(Acetyloxy)-3-nitrobenzoic acid